Medical

3D Printing in Hospitals

In recent years, many hospitals have started making a shift, from using medical images primarily for diagnostic purposes, to integrating them in patient-specific surgical planning. This has created enormous advantages for hospitals and their patients and is largely supported by the clarifying regulatory landscape, increased governmental support, new public and private initiatives, and the expanding role of the radiologist as an imaging expert. As part of this, an increasing number of hospitals across the world have integrated the practice of 3D printing into their medical care. Hospitals are recognizing the added value it brings to personalized patient care and the countless possibilities that are becoming a reality, in creating better treatment options.

Speakers:

Kerim Genc

blank

Kerim Genc is the Business Development Manager for the Simpleware Product Group at Synopsys.  He joined Simpleware in 2011 and is currently responsible for managing global sales, business development, partnerships and technical marketing content development, with a significant focus on image-based patient specific workflows for 3D Printing and surgical guides/planning.  He received his BS and MS in biomechanics from the University of Calgary and the Pennsylvania State University respectively, and completed his PhD in Biomedical Engineering at Case Western Reserve University, examining countermeasures to and computational models of spaceflight induced bone loss and fracture risk.

Shannon Walters

blank

Shannon Walters is an innovation enabler and workflow-optimization enthusiast. At Stanford 3D and Quantitative Imaging Lab, Shannon works closely with healthcare providers, researchers, and educators to enable effective health visualization. 

Recent innovations are of particular interest to Shannon such as 3D Printing, immersive volumetric visualization, and concise reporting of changes over time. 

Paul Fotheringham

blank

Paul Fotheringham is the founder of 3D LifePrints (3DLP) and is an experienced Technologist, Entrepreneur, and 3D printing expert who focuses on the medical sector. He holds a joint Bachelor of Science degree in Computer & Management Science from the University of Edinburgh. After graduating, he worked in over 10 countries including the US, UK, HK, Japan, and South Korea as an Enterprise Architect for organizations such as the London Stock Exchange, British Petroleum, Accenture and Macquarie Group. In 2012 he took up a post as Chief Technology Officer for a global Micro-finance organization in Kenya where he subsequently started 3DLP initially as a Social Enterprise in order to provide sustainable, affordable and suitable 3D printed prosthetics for developing world amputees. He currently overseas 3DLP’s European operations from Barcelona that provide a variety of innovative medical 3D printing products and services to medical institutions.

Albert Woo

blank

Albert S. Woo, MD, FACS is a board-certified plastic and reconstructive surgeon specializing in craniofacial surgery. This work has led to a particular interest in three dimensional imaging and printing of complex surgical models. He is an Associate Professor of Surgery, Pediatrics and Neurosurgery at The Warren Alpert Medical School of Brown University and serves as the Chief of the Division of Pediatric Plastic Surgery, Director of the Cleft and Craniofacial Center at Hasbro Children’s Hospital, and is the founding Director of the Lifespan 3D Printing Laboratory.

blank

Microfluidics, Technology, Commercialization

“Microfluidics refers to the behavior, precise control, and manipulation of fluids that are geometrically constrained to a small scale (typically sub-millimeter) at which surface forces dominate volumetric forces. It is a multidisciplinary field that involves engineering, physics, chemistry, biochemistry, nanotechnology, and biotechnology. It has practical applications in the design of systems that process low volumes of fluids to achieve multiplexing, automation, and high-throughput screening. Similar to 3D printing, microfluidics emerged at the beginning of the 1980s and is used in the development of inkjet printheads, DNA chipslab-on-a-chip technology, micro-propulsion, and micro-thermal technologies, organ-on-a-chip, and more. 3D printing has been both a manufacturing method and an application for microfluidics. 

Speakers:

Albert Folch

blank

Albert Folch received his BSc in physics from the University of Barcelona (UB), Spain, in 1989. In 1994, he received his Ph.D. in surface science and nanotechnology from the UB’s Physics Dept. During his Ph.D. he was a visiting scientist from 1990–91 at the Lawrence Berkeley Lab working on AFM under Dr. Miquel Salmeron. From 1994–1996, he was a postdoc at MIT developing MEMS under the advice of Martin Schmidt (EECS) and Mark Wrighton (Chemistry). In 1997, he joined the laboratory of Mehmet Toner as a postdoc at Harvard’s Center for Engineering in Medicine to apply soft lithographic methods to tissue engineering. He has been at Seattle’s UW BioE since June 2000 where he is now a full Professor, accumulating over 6,700 citations (averaging >82 citations/paper over his whole career). His lab works at the interface between microfluidics, cancer, and neurobiology. In 2001 he received an NSF Career Award and in 2014 he was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows (Class of 2015). He serves on the Advisory Board of Lab on a Chip since 2006. Albert Folch is the author of four books, including “Introduction to BioMEMS”, a textbook now adopted by more than 77 departments in 17 countries (including 40 universities in the U.S. alone). Since 2007, the lab runs a celebrated outreach art program called BAIT (Bringing Art Into Technology) which has produced seven exhibits, a popular resource gallery of >2,000 free images related to microfluidics and microfabrication, and a YouTube channel that plays microfluidic videos with music which accumulates ~133,000 visits since 2009.

Mohsen Akbari

Mechanical Engineering, University of Victoria

blank

Dr. Mohsen Akbari is an Associate Professor of Mechanical Engineering and the Director of the Laboratory for Innovations in Microengineering (LiME) at the University of Victoria. In addition to his professorship, he is a member of the Center for Advanced Materials and Related Technologies (CAMTEC), member of Center for Biomedical Research (CBR), investigator at International Collaboration on Repair Discoveries (ICORD), Associate Member of Djavad Mowafaghian Centre for Brain Health and the co-founder and Chief Scientific Officer at 4M Biotech. Dr. Akbari obtained his Ph.D. from Simon Fraser University and his postdoctoral training at Harvard Medical School and Brigham and Women’s Hospital. He is the recipient of several awards, including the NSERC Postdoctoral Fellowship Award, Michael Smith Foundation Idea to Commercialization Awards, BC Innovation Council Research Award, Kaiser Foundation Award, and recognized as a Canadian Rising Star in Global Health by Grand Challenges Canada. Dr. Akbari’s research lies at the interface of cellular biology, biomaterials, and microtechnologies and aims to develop innovative approaches for disease modelling and drug delivery. He currently holds funding from CIHR, NSERC, CFI, BC Cancer Foundation, and the Department of National Defense. He is a Guest Editor of Micromachines and Gels and a member of the Board of Directors of the Canadian Society for Mechanical Engineering. His research findings have been published in 90 peer-reviewed journal papers and book chapters with an h-index of 35 and over 5300 citations. His work has been featured on the cover of 11 Journals and reported in media such as CBC News, Time Colonist, BBC News, Google News, Science Daily, The Telegraph, and Fortune.

Nick Allan

blank

Nick Allan is the Bio Services Manager at StarFish Medical. Allan joined the company as a Project Manager, becoming Bio Service Manager in 2016. He has provided innovative solutions to client issues ranging from proof-of-concept studies for rapid detection point of care assays to full-scale regulatory submission studies, and designed and facilitated more than 500 Unique Research Protocols. Allan is President of Chinook Contract Research, co-founder and former GM of The Institute for Applied Poultry Technologies, and former Contract Research Manager at Innovotech Inc. Allan holds an MS in Microbiology and BS in Biology from the University of Guelph.

Simon Beyer

blank

Simon is the Chief Technology Officer at Aspect and oversees the advancement of our biomanufacturing technologies. He leads our engineering teams and the development of our core technologies, including bioprinting systems, microfluidic printheads, biomanufacturing automation, tissue design software, and machine learning. Simon is a principal inventor of Aspect’s microfluidic bioprinting technology with broad expertise developing advanced printing systems for applications including printed electronics, self-assembling nanomaterials, and biological tissue.

Simon holds a B.A.Sc. and M.A.Sc. in Electrical Engineering from the University of British Columbia

Moderator:

Kate Clancy

blank

Kate Clancy is a Research Associate at Angle Biosciences Inc.(ABI) and a 3DHEALS Community Manager. At ABI, she works on both engineering and surface coating projects to design fluidic devices. Kate holds a MEng in Biomedical Engineering from McGill University and BSc in Biochemistry from the University of Guelph.

blank

3D Bioprinting for Food

Lately, 3D printing food has become a hot topic, as climate change and the impending water shortage crisis all beckon humanity for alternative more environmental (and healthier) food sources. “Cultured meat”, “cellular agriculture”, “lab-grown meats” are all new popular concepts that are receiving increasing attention. What are the roles of 3D printing in all this? What are the issues entrepreneurs and scientists facing? Who are the influencers, rising startups, regulatory bodies for this emerging field? How is the culinary world receiving the 3D printing concept? 

Speakers:

Avery Parkinson

blank

Avery is the Executive Director of Cellular Agriculture Canada. She has been passionate about cell ag technology for a couple of years now and has held positions at Tufts University, Big Idea Ventures, the Good Food Institute, and the Protein Report where she has worked on creating educational content and resources to grow the industry nationally and worldwide.

Kyle Von Hasseln

blank

Kyle von Hasseln is an American inventor, entrepreneur and adventurer. He graduated Middlebury College with a focus in molecular ecology. He was awarded the Frank Gehry Prize for Best Thesis at the Southern California Institute of Architecture, where he invented and patented the first dehydrated food 3D printer. His startup, Sugar Lab, was acquired by 3D Systems where he led the development of the first NSF certified commercial food 3D printer. In 2020 he founded Culinary Printworks, the first on-demand culinary 3D printing firm, and brought back the retail Sugar Lab brand. Kyle is an avid backcountry skier, surfer, and alpine rock climber.

Roger Kuan

blank

Roger Kuan is a Partner at Haynes and Boone and chair of the Precision Medicine and Digital Health Practice Group, where he counsels companies that are uniquely positioned in the convergence of the life/medical sciences and technology industries on how to successfully navigate the complexities of the intellectual property (IP), data rights and regulatory challenges they encounter.Roger has extensive experience in IP strategy and portfolio management (utility/design patents, trademarks, copyrights, and trade dress), data rights strategy, licensing and technology transactions, freedom-to-operate clearances, enforcement, monetization, IP due diligence, and dispute resolution. His practice is focused in the life sciences sector (e.g., research tools, analytical instrumentation/software, digital therapeutics, medical devices, diagnostics, biomanufacturing equipment, etc.) with an emphasis in emerging technologies such as Precision Medicine (e.g., genomic sequencing platforms, AI/ML, computational genomics/bioinformatics, molecular diagnostics, companion diagnostics, etc.), Digital Health (e.g., mobile apps, clinical decision support, software, digital therapeutics, AI/ML Imaging Diagnostics, wearables, etc.) and 3D printing/bioprinting. Prior to joining Haynes and Boone, Roger served as Director, IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, he worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.

Simon Fried

blank

Simon, head of business at MeaTech, grew up around restaurants, has business experience including food retail, FMCG, distilleries and 3D printing. Combined with his academic background in risk, behavioral economics, and behavior change, he’s excited to be playing a part in the cultivated meat transformation.

Moderator:

Dr. Vidya Chamundeswari Narasimhan

 3DHeals Community Manager – San Francisco

blank

Dr. Vidya is currently heading the Biomaterials engineering division at NEW AGE MEATS – Berkeley, California. She received her Ph.D from Nanyang Technological University(NTU), Singapore in 2018. Her research focused on developing bioactive polymeric scaffolds for musculoskeletal tissue regeneration applications.

During her post doctoral fellowship in Singapore, Vidya spearheaded various academia-industrial collaborative projects. At 3DHEALS, she is our Community Manager of San Francisco Bay Area and is also actively involved in STEM mentorship and in tutoring University and Junior college students for various competitive examinations.  

Vidya has been actively involved in research pertaining to sustainability within the agro-food and biomaterials sector, and is passionate about emerging technologies in the field of 3D bioprinting. She hopes to actively share and spread this interest amongst like minded professionals in the field of  regenerative medicine and tissue engineering. Currently Vidya has contributed to a couple of expert column blogs on bone tissue engineering and is the co-instructor of an online course on Bioinks used for Bioprinting available on Udemy!

blank

3D Printing in Orthopedics

In this virtual event focusing on 3D printing in Orthopedics, we feature a panel of international influencers, rising startups, and hot topics to both learn and discuss what innovators and entrepreneurs are experiencing from their personal perspectives, ranging from metal 3D printing, implants, to various other 3D technologies that are related to 3D printing surgical planning tools, such as AR/VR/MR. Through the conversation, we hope to learn more about current industry landscape and trends.

Speakers:

Dr. Alan Dang

blank

Dr. Alan Dang is a board-certified, licensed orthopaedic spine surgeon. He is an HS Clinical Associate Professor at UCSF. Along with his brother, Dr. Alexis Dang, he started the Orthopaedic Rapid Intelligent Fabrication (ORIF) program at UCSF/San Francisco VA and is a founding member of the UCSF Center for Applied 3D+ Technologies. Dr. Dang is also a capstone mentor and member of the selection committee for the UCSF/UC Berkeley Masters in Translational Medicine program.

Brian McLaughlin

blank

Brian is the founder of Amplify Additive. He is passionate about orthopedics and is well-versed in all aspects of advanced manufacturing – from the industry’s leading innovators and product development to commercialization strategies and business trends. Creative and entrepreneurial by nature, Brian’s attention is on identifying opportunities for new business development in existing and emerging orthopedic markets, and in assisting companies looking to leverage AM technology.

Brian and his team at Amplify are focused on advancing Additive Manufacturing for Orthopedics, utilizing GE Additive’s Arcam Electron Beam Melting (EBM) technology for innovative implant solutions across all indications. Brian has experience across all industry lines in the orthopedic market including design & manufacturing for a leading CMO; as a clinical specialist working directly with surgeons; as the VP of Engineering and co-founder of a Foot & Ankle implant company leveraging AM for implants; and now as the leader at Amplify Additive.  Brian has a BS in Biomedical Engineering from the University of Vermont.  

Brian lives in Yarmouth, ME with his wife and two sons. In addition to his passion for the orthopedic market, he enjoys playing and coaching soccer, alpine skiing, cycling, running and occasionally golfing.

Interview with Dr. Alan Dang, co-Founder of PrinterPrezz

Dr. Bruno Gobbato

blank

Dr. Gobbato is an orthopedic surgeon and specialist in the anatomy of shoulders and elbows. He has been a part of 3D printing in medicine and orthopedic models since 2013. Works with mixed reality and Artificial Intelligence. 

Interview with Dr. Bruno Gobbato: 3D Printing Orthopedics

Dr. Richard Hurley

blank

Dr. Richard Hurley is an orthopaedic surgeon with over a decade of experience in medical 3D printing. He is an assistant professor at Dalhousie University in Halifax, Nova Scotia specialising in hip and knee replacement surgery. In 2012 he co-founded Conceptualiz to provide easy to use virtual surgical planning and medical 3D printing software to healthcare providers. He is the director of the in-hospital medical 3D printing lab at the Dartmouth General Hospital. He is also the curator of the 3D Orthopaedic Special Interest Group (3DOS) and was a former computer assisted surgery product manager for DePuy Canada.

Moderator:

Dr. Nathan J. Castro

blank

Dr. Nathan J. Castro is an experienced biomedical researcher and entrepreneur.  He has assisted in the design, testing, regulatory approval and clinical translation of 3D printed medical devices, as well as co-founded Nanochon, Inc.  He is skilled in policy analysis, life sciences, data analysis, and quantitative research with particular interest in clinical translational (bench-to-bedside).  With domestic and international research appointments at well-recognized laboratories, Dr. Castro is always in search of opportunities to leave a positive impact on whomever he has the pleasure of working with.

blank

3D Printed Orthotics and Prosthetics

Over the years, the images of disabled children with colorful prosthetic limbs inspired impactful movements like the ENABLE community and Victoria Hand Project, as well as enumerable passionate innovators who have pushed the boundaries to increase accessibility and lower the cost of orthotics and prosthetics. However, the field of 3D printed orthotics and prosthetics has advanced significantly since the days of ENABLE hands. These advancements include not just hardware, materials, but also software, designs, 3D scanning, and lately completely digitalized workflow at the point of care, often leveraging machine learning and artificial intelligence. More importantly, technologists are now working more closely with clinicians to create a more efficient and more evidence-based patient-centered clinical solution. 

Speakers:

Jonathan Borduas

blank

Jonathan Borduas founded Shapeshift 3D in 2019 to focus on bridging the gap between 3D Scanning and 3D printing technologies. A pioneer in the additive manufacturing revolution, Jonathan commercialized one of the first 3D-printed knee braces across North America in his first venture with Canadian-based orthotics company, Osskin. Through the Shapeshift 3D patented technology, Jonathan is determined to find new ways to approach custom-fit, and to open the door to mass customization.

Jeffrey Chang

blank

Jeffrey graduated from the University of British Columbia from the Engineering Physics program.

He then went on to work in manufacturing; working as a CNC programmer / operator for a year and a half.  From there, he graduated to Vorum.  Jeffrey has worked in the O&P industry just over 20 years, doing support and sales activities and has recently (5yrs ago) settled into R&D.

Jeffrey has a passion for innovation and currently spends most of his time some way or another playing with 3D printers.

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS. Her main interests include medical education, 3D printing in the healthcare sector, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.

Hargurdeep (Deep) Singh

blank

Hargurdeep (Deep) Singh has 10+ years of experience in the Additive Manufacturing industry and has held various positions in research & development, engineering services, and management. He focuses on helping manufacturing companies take advantage of the latest digital manufacturing and industry 4.0 technologies.

Deep has worked with numerous customers in a variety of industries to digitalize its operations. He is currently a Vice President of Advanced Manufacturing at CAD MicroSolutions Inc (Canada’s largest industry 4.0 value-added integrator) and a globally recognized thought leader in the Additive Manufacturing ecosystem.

Before joining CAD MicroSolutions, Deep’s work in Additive Manufacturing / 3d printing has resulted in award-winning research and design. He is the recipient of the Indo-Canada Chamber of Commerce Young Achiever Award; Brampton Board of Trades Top 40 under 40 Award; the ASME Innovative Additive Manufacturing 3D (IAM3D™) Global Challenge winner; OACETT Publication Award; valedictorian of Sheridan Mechanical Engineering studies; and has been featured in various magazines and media articles for his innovative projects.  

Samer Moussa

blank

Samer has a background that merges design, clinical care and business development of medical devices. With an undergrad in Mechanical Engineering, a Masters of Science in Orthotics and Prosthetics and currently pursuing an MBA, he has transitioned from everyday clinical care as a CPO to working as a product manager with different medical device manufacturers. From adjustable prosthetic sockets with LIM Innovations, to innovative off the shelf knee and spine devices with Breg and the latest venture with HP, Arize Orthotics which is a fully developed end to end solution for custom orthotics.

Samer has been in the O&P industry for 10 years and his main passion is finding the right bridge between new technology and clinical pain points in a way that both businesses can strive.

blank

3D Printing for Medical Simulation

Medical simulation either for education or surgical training has been one of the first applications leveraging 3D printing (additive manufacturing). With the rapid progress made in healthcare 3D printing machinery, software, and materials, innovations within this sector have also made significant advances in the last few years.

Speakers:

Abdel Hakim Moustafa

blank

Abdel Hakim Moustafa, MD is a cardiologist at the Hospital de la Santa Creu i Sant Pau, Barcelona, specialized in multimodality cardiac imaging (Cardiac CT, Cardiac MR, echocardiography) with a focus on structural and valvular heart diseases. 

He is an expert in medical 3D printing, 3D modelling and advanced visualization to create patient specific anatomical models for pre-procedure planning and training, as well as the development and testing of medical devices. He founded the Sant Pau Hospital 3D lab 2 years ago, and collaborates closely with the HP 3D Printing to create patient and pathology specific training simulators for Edwards Lifesciences and NaviGate Cardiac Structures, among others.

Robert S. Pugliese

blank

Robert S. Pugliese is Director of Innovation Design at Thomas Jefferson University and Jefferson Health where he co-founded the Health Design Lab, a creative space built with the purpose of merging together design-studio ethos with science-oriented discipline to foster innovation in healthcare. As somebody who enjoys empowering future health care providers to be change makers, Robert leads programs that train students to be health design thinkers and innovators. A Doctor of Pharmacy (PharmD), Robert has spent over ten years practicing and teaching in Emergency Medicine. He believes that including both the patient and provider voice is vital to healthcare design, and he brings each of these perspectives to his work through his experience as a clinician and through his own journey coping with insulin-dependent diabetes. Robert has presented on the intersection of healthcare and design at national venues such as SXSW and Stanford Medicine X and in 2019 he was selected as a Philadelphia Business Journal 40 Under 40 honoree. Throughout the COVID-19 pandemic Robert has used his unique experience to lead critical response efforts to overcome supply chain short falls and respond to community needs for testing and vaccination. In his spare time, Robert produces a weekly podcast and enjoys spending time with his wife and three daughters.

Stephen Wilson

blank

Talk title: Advantages of 3D Printer Use by a Hospital-Based Simulation Program

Stephen Wilson is Director of Engineering at Boston Children’s Hospital’s on-site pediatric Simulator Program (SIMPeds). Steve and his team collaborate directly with clinical partners to design and develop custom medical engineering solutions seamlessly integrated with patient care. Focused on bedside impact, the SIMPeds Engineering Studio provides a wide range of services including using 2D medical imaging to create patient-specific digital and 3D-printed models to support diagnosis, treatment and surgical planning. These creations provide clinicians with critical context and details regarding the patient’s anatomy that routinely change clinical approaches and impact patient outcomes.

Steve and his team also provide a vast array of tools for clinicians to improve their practice and patient outcomes, these include lifelike devices to enhance simulation-based clinician training & education, immersive technology solutions (e.g., Virtual Reality, Augmented Reality, 360 video) for clinician training and patient family support, and the design and fabrication of novel medical devices using in-house “Makerspace” resources.

Steve’s decades of experience in the medical device industry creating implants, instruments and equipment used in sports medicine, general surgery/trauma, orthopedic surgery & neurosurgery, has defined his passion to create practical and elegant solutions that improve health care.

Ziad Rouag

blank

Ziad brings more than two decades of experience working in the medical device industry as an executive and leader of clinical operations and regulatory affairs for emerging startups and high-growth businesses. He currently serves as President and CEO of Biomodex, a transformative digital healthcare company offering bio-realistic haptic simulators for patient-specific rehearsal and physician training.  Prior to Biomodex, Ziad served as Vice President of Regulatory and Clinical Affairs at Juul Labs, which was acquired by Altria in 2018. Previously, he served as Vice President of Regulatory and Clinical Affairs for PQ Bypass, a pioneering Fogarty Innovation startup that was recently acquired by Endologix for more than $300 million. In 2013, Ziad served as Vice President of Regulatory, Clinical and Quality Affairs for Altura Medical before the endovascular repair device maker was acquired by Lombard Medical for $50.5 million. His diverse work experiences include senior positions at Bay Area Biotech, Auxogyn, and Avinger, Codman, Evalve, and Guidant. Ziad received both a BS and BA from McGill University and a J.D. from Rutgers University.

blank

Biomaterials For 3D Printing

Biomaterial science is one of the major pillars of successful 3D printed solutions for healthcare. In this webinar, we invited stakeholders from academia, industry, larger chemical and material companies, and rising startups to give you a comprehensive view of where material science technology for healthcare 3D printing is at.

Speakers:

Astrid Ahlinder

blank

Astrid Ahlinder holds a PhD in Polymer technology from KTH Royal institute of technology in Sweden. She trained as a Biomedical Engineer in Glasgow, UK, during her PhD she looked into the effect of processing parameters when 3D printing degradable polymer for soft tissue engineering; the synergy between inherent material properties, processing parameters and design of the final structures. She has taken part in starting up AKIRA Science, a spin off from the research group at KTH looking to supply researchers and surgeons with degradable pliable polymers and 3D printed structures for tissue engineering. Her primary interest is the relationship between material science, processing and tissue engineering.

Balaji Prabhu

blank

Balaji Prabhu is Director Global R&D, 3D printing at Dentsply Sirona. 

His experience in medical device and biomaterials includes various leadership roles at Stryker Orthopaedics and Evonik Corp. 

His diverse experience includes R&D, scale-up, marketing, manufacturing and business development leading multiple medical device innovations from concept to commercialization. 

Balaji led the setting up and commercialization of Evonik’s Medical Device Competence Center (MDCC) in Birmingham, Alabama which is also the 3D printing Center of Excellence for polymers. His career involves bringing various cutting-edge platform technologies including 3D Printing through successful commercialization for human use. 

He holds Graduate degrees in Materials Science Engineering, Executive Technology Mgmt., and an Executive MBA in Innovation & Technology Management.

Nadav Orr

blank

Talk title: Collagen BioInk Platform for 3D Bioprinting of Tissues and Organs

Nadav Orr, PhD, VP R&D at CollPlant Ltd, joined CollPlant in 2014. He is leading a multidisciplinary R&D team towards the development of technology platforms and clinical applications in the field of regenerative medicine.  Prior to this, Nadav served as an Associate Director and Manager of an R&D group at Omrix Biopharmaceuticals Ltd., a subsidiary of ETHICON Biosurgery, a Johnson & Johnson company. While at Omrix, Nadav led an international team developing hemostatic combination products and led base business support for production processes and products. Nadav holds a PhD in immunology from the Weizmann Institute of Science.

Scott DeFelice

blank

Prior to founding OPM in 2000, CEO and Chairman Scott DeFelice was co-founder and Vice President of Marketing at Oxford Polymers, a compounder of engineered thermoplastics, where he led the firm’s innovation, strategy, and business development activities.

Mr. DeFelice has grown OPM to become a recognized leader in 3D printing and high performance additive manufacturing (HPAM™). A proven entrepreneur in the fields of cutting edge materials and additive manufacturing, DeFelice’s company has developed a range of advanced materials technology focused on a high performance polymer, poly-ether-ketone-ketone (PEKK), and delivers enterprise level, functional end-use products to the biomedical, aerospace and industrial markets as the first company to successfully apply additive manufacturing solutions to PEKK.

In addition to OPM, Mr. DeFelice serves on the Sustainability Committee of America Makes – the National Additive Manufacturing Innovation Institute. Mr. DeFelice holds a BA from the University of Connecticut and an MSc from the University of Strathclyde, Scotland. He is married with two children and is active in cycling and golf.

Moderator:

Joe Borrello

blank

Joe is currently a biomedical engineer and PhD Candidate at Mount Sinai, working in the labs of Drs. Kevin Costa and Junqian Xu, in addition to being the lead engineer with the Sinai BioDesign innovation team and helping run the MSIG and GRO-Biotech student groups. Previously, he worked at 3D Systemson technical development in the consumer marketing department and as a liaison with engineering project management teams, in addition to an earlier stint at experiential marketing firm Affinitive.

Joe received his bachelors in Biomedical Engineering from Macaulay Honors College at The City College of New York, where he also remains active in the Zahn Innovation Center, an on-campus tech startup incubator.

He has also been involved in several startup ventures in the hardware and biotech spaces. Several years ago, Joe took Proto-Sauce, through NYCEDC’s Futureworks Incubator, with the goal of developing new materials for resin-based 3D printing. More recently, he had the privilege to serve as the CTO of BioSapien, using advanced manufacturing to create new devices for the treatment of cancer. Beyond Joe’s direct startup work, he has also continued to participate in Futureworks and other New York City startup programs as a mentor.

blank

The Legal Landscape in Healthcare 3D Printing

It is our experience that risk can be mitigated with knowledge. In the upcoming months, we plan to invite legal and regulatory experts to provide foundation knowledge and updates on the legal landscape in healthcare 3D printing. These webinars will focus on critical issues faced by entrepreneurs and startups in the healthcare 3D printing ecosystem, ranging from intellectual property, medical device liability, as well as FDA and CE regulations and guidance, focusing both on biological and non biological devices.

Speakers:

Sean Burke

Sean Burke profile

Sean Burke is partner and vice chair of the products liability trial division at Duane Morris. He is in the firm’s Washington, DC office.  Mr. Burke’s practice focuses on representation of manufacturers of medical devices in products liability cases across the country, including in consolidated multi-plaintiff matters in both federal court and state courts. His experience includes defense of large total joint replacements (hips, knees, ankles, and shoulders) and resurfacings, tissue matrices and patches, fusion plates, and surgical instruments.  He has a particular interest and focus on additive manufacturing, consulting and advising clients on best practices in the early stages of development to reduce risk of products liability exposure.  He has tried medical device cases before juries in both state and federal courts while also handling numerous mediations.  He works closely with scientific experts to advance causation and liability defenses in the areas of biomechanical engineering, toxicology, histology, epidemiology, orthopedic surgery and FDA regulations.

Roger Kuan

blank

Roger Kuan is a Partner at Haynes and Boone and chair of the Precision Medicine and Digital Health Practice Group, where he counsels companies that are uniquely positioned in the convergence of the life/medical sciences and technology industries on how to successfully navigate the complexities of the intellectual property (IP), data rights and regulatory challenges they encounter.Roger has extensive experience in IP strategy and portfolio management (utility/design patents, trademarks, copyrights, and trade dress), data rights strategy, licensing and technology transactions, freedom-to-operate clearances, enforcement, monetization, IP due diligence, and dispute resolution. His practice is focused in the life sciences sector (e.g., research tools, analytical instrumentation/software, digital therapeutics, medical devices, diagnostics, biomanufacturing equipment, etc.) with an emphasis in emerging technologies such as Precision Medicine (e.g., genomic sequencing platforms, AI/ML, computational genomics/bioinformatics, molecular diagnostics, companion diagnostics, etc.), Digital Health (e.g., mobile apps, clinical decision support, software, digital therapeutics, AI/ML Imaging Diagnostics, wearables, etc.) and 3D printing/bioprinting. Prior to joining Haynes and Boone, Roger served as Director, IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, he worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS. Her main interests include medical education, 3D printing in the healthcare sector, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.

blank

3D Bioprinting Vasculatures

3D bioprinting vasculatures is perhaps the holy grail of the next industrial revolution in healthcare. Biofabrication and bioprinting of any viable three-dimensional tissue will not be successful unless the vascularization challenge has been solved. Many organizations and talents around the world are actively tackling this challenge, but where are we exactly?

Speakers:

Andrew Hudson

blank

Andrew received his B.Sc. in Materials Science and Engineering (2014) and M.Sc. in Biomedical Engineering (2015) from Carnegie Mellon University. He is currently a Ph.D. student in Adam Feinberg’s Regenerative Biomaterials and Therapeutics Group. The goal of Andrew’s research is to vastly improve the resolution and vascularization in 3D bioprinting to create the next generation of tissue engineered therapies such as cardiac muscle. Andrew is also a Co-Founder of FluidForm, a CMU startup that seeks to spread the FRESH 3D bioprinting technology developed in the Feinberg lab. 

Jordan Miller

blank

Jordan Miller is an Associate Professor of Bioengineering. at Rice University and Co-Founder of Volumetric, a Houston-based startup focused on next-generation biomaterials and biofabrication technologies. Miller received his bachelor’s degree in Biology from MIT in 2003 and earned his Ph.D. in Bioengineering from Rice University in 2008. His primary interests combine synthetic chemistry, 3D printing, microfabrication, and molecular imaging to direct cultured human cells to form more complex organizations of living vessels and tissues for research in regenerative medicine. Precisely engineered in vitro systems at the molecular, micro- and meso-scale are well suited to decouple the relationship between tissue architecture and cell function. These systems are now permitting comprehensive closed-loop design and optimization of large-scale engineered tissues through refinement with computer models of mass transport and assessment of their therapeutic potential in vivo.

Prafulla Chandra

blank

Dr. Prafulla Chandra is an accomplished life science professional with current specialization in regenerative medicine, 3D bioprinting, and cell biology. He has a Ph.D. in Biotechnology from the University of Pune (India), and more than 16 years of combined scientific research experience. His unique combination of skills and experience include research, technology development and intellectual property related to biomedical and regenerative medicine products. Dr. Chandra has been working at the Wake Forest Institute for Regenerative Medicine (WFIRM) since the past 7 years under the mentorship of Dr. Anthony Atala, where his work in 3D bioprinting includes using extrusion and ink-jet based bioprinters for creating live tissues such as cartilage, bone, skin, urethra and many types of polymer scaffolds for tissue regeneration and diagnostic applications such dermal scaffolds, microfluidics-based cell culture and organ-on-a-chip systems. Additionally, adapting synthetic polymers for 3D bioprinting, creating self-expanding polymers, bioink development, stem-cells based therapies and organ-on-a-chip for screening and diagnostic applications are his other projects at WFIRM. In association with the Regenerative Medicine Clinical Center (RMCC) at WFIRM, Dr. Chandra has also worked on clinical translation of regenerative medicine products, which include an oxygen-generating wound dressing and a 3D bioprinted nasal septum cartilage. He was a core team member for validating a 3D bioprinter for clinical manufacturing and also participated in the writing of regulatory documents such as pre-IND and IND for submission to the US FDA. Prior to joining WFIRM, Dr. Chandra had worked at the New Jersey Center for Biomaterials (under the mentorship of Prof. Joachim Kohn, Director, New Jersey Center for Biomaterials, Rutgers University, NJ, USA), where his work included research in the fields of cell-biomaterial interactions, human skin tissue engineering, surface modification of polymers for enhancing cellular response and using synthetic polymer-based nanospheres for enhancing topical delivery of hydrophobic drugs. One of his research here led to the award of a US Patent (Patent No. 8414871) on which he is a co-inventor.

James (Jay) Hoying, Ph.D.

blank

James (Jay) Hoying, Ph.D. is Partner and Chief Scientist of Advanced Solutions Life Sciences (ASLS), a company pioneering solutions in tissue fabrication and biomanufacturing. Prior to joining ASLS, Dr. Hoying was the Chief of the Division of Cardiovascular Therapeutics at the Cardiovascular Innovation Institute (CII) and a Professor in the Department of Physiology at the University of Louisville. He has over 25 years of experience in basic and applied biological sciences research with a focus in tissue biology, tissue vascularization, and the microcirculation. In addition to his numerous published works, Dr. Hoying holds patents related to vascularizing tissues and related cell-based therapies; technologies that have been translated to companies, including start-ups and ASLS. Dr. Hoying is a Fellow of the American Heart Association.

Moderator:

Lehanna N. Sanders, PhD

Business Development Manager, Advanced Solutions Life Sciences

blank

Dr. Lehanna Sanders is a cellular and molecular biologist and has done research within the field of regenerative medicine for 8 years.  She received her Bachelor’s degree in Cellular, Molecular, and Development Biology from Purdue University where she completed an honors thesis project in Biomedical Engineering.  She then completed her PhD at Vanderbilt University where she published work in the area of molecular repair processes following acute cardiac injury.  During her time at Vanderbilt, she served on the Skills Development Committee for the NHLBI Progenitor Cell Biology Consortium, as well as a member of the Board of the Directors for the Life Science Tennessee-Academic Alliance.  She now works in Business Development for Advanced Solutions Life Sciences, where she is continuing to grow the field of regenerative biology through working closely with scientists and engineers to advance innovations in 3D bioprinting and biofabrication.